Thursday, October 1, 2026
The top medical stories of the day, as they ran.
Morning edition
15 stories
- 1Pennsylvania reports fifth measles-associated death this yearOutbreaks · 5 outlets
- 2CMS finalizes Medicare model tying Part B drug rebates to international pricesMedicare and Medicaid · 4 outlets
- 3Lilly combination produced 23.3% weight loss in mid-stage trialResearch · 4 outlets
- 4Retatrutide trial finds weight loss in adults with diabetes and obesityDiabetes and obesity · 3 outlets
- 5Medicaid changes put hundreds of thousands of legal immigrants at risk of losing coverageMedicare and Medicaid · 2 outlets
- 6Rural MAHA supporters see little health benefit from Trump policiesHealth policy · 4 outlets
- 7Bristol Myers reports liver safety events, including a patient death, in trialDrug safety · 2 outlets
- 8Roche and Zealand report phase 2 petrelintide weight-loss resultsDrugs and FDA · 2 outlets
- 9UK studies find robotic joint replacement does not reduce repeat surgeryResearch · 3 outlets
- 10Giredestrant and everolimus extended progression-free survival after CDK4/6 treatmentCancer · 2 outlets
- 11ACC statement urges overall diet quality for cardiovascular healthHeart health · 2 outlets
- 12ACC issues guidance on HFpEF, frailty and myocardial infarctionHeart health · 1 outlet
- 13Merck reports phase 2b success for tulisokibart in hidradenitis suppurativaResearch · 2 outlets
- 14FDA opens nationwide recruitment for advisory committee membersDrugs and FDA · 2 outlets
- 15England to expand Healthy Babies programme to all local authoritiesPublic health · 2 outlets
Evening edition
19 stories
- 1Pennsylvania reports fifth measles-associated deathOutbreaks · 5 outlets
- 2Lilly reports 23.3% weight loss with eloralintide-tirzepatide comboDiabetes and obesity · 4 outlets
- 3Survodutide cut weight by up to 9.8% in adults with diabetes and obesityDrugs and FDA · 5 outlets
- 4CMS finalizes Medicare model tying Part B drug rebates to international pricesMedicare and Medicaid · 3 outlets
- 5Tennessee reviews how Christa Pike survived two pentobarbital dosesDrug safety · 4 outlets
- 6HHS launches programs to speed clinical trialsResearch · 3 outlets
- 7FDA approves mavacamten for children with obstructive HCMDrugs and FDA · 4 outlets
- 8Sanofi and Regeneron expand alliance with $1 billion upfront paymentIndustry · 5 outlets
- 9Alabama, Arkansas and Louisiana ask Supreme Court to block abortion shield lawsHealth policy · 3 outlets
- 10Bristol Myers reports fatal liver injury in pulmonary fibrosis trialDrug safety · 3 outlets
- 11IARC study links 2.3 million 2024 cancer cases to infectionsResearch · 3 outlets
- 12Officials warn cychlorphine is spreading across statesPublic health · 1 outlet
- 13FDA approves adjustable pulmonary valve designed to grow with childrenMedical devices · 2 outlets
- 14The New York Times examines ketamine effects amid Cornell assault allegationsDrug safety · 3 outlets
- 15FDA approves tavapadon as a Parkinson’s disease treatmentDrugs and FDA · 2 outlets
- 16Claims data show sharp rise in postpartum GLP-1 prescriptionsMaternal health · 2 outlets
- 17Foghorn cuts 40% of workforce after Lilly collaboration endsIndustry · 2 outlets
- 18Physician groups push back on Kennedy’s comments about AI in health careHealth policy · 2 outlets
- 19Higher daily step counts linked to fewer mental health problems in adolescentsResearch · 2 outlets